THE PHARMACOKINETICS OF GLYCYRRHIZIC ACID EVALUATED BY PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING^†

REFERENCES

• Olukoga A., Donaldson D. Historical Perspectives on Health. The History of Liquorice: The Plant, Its Extract, Cultivation, Commercialisation and Etymology. J. Roy. Soc. Health 1998; 118(5)300–304
   Google Scholar
• Fenwick G. R., Lutomski J., Nieman C. Liquorice, Glycyrrhiza glabra L.—Composition, Uses and Analysis. Food Chem. 1990; 38: 119–143
   Web of Science ®Google Scholar
• Davis E. A., Morris D. J. Medicinal Uses of Licorice Through the Millennia: The Good and Plenty of It. Mol. Cell. Endocrinol. 1991; 78(1–6)1–6
   Web of Science ®Google Scholar
• Walker B. R., Edwards C. R. Licorice-Induced Hypertension and Syndromes of Apparent Mineralocorticoid Excess. Endocrinol. Metab. Clin. North Am. 1994; 23(2)359–377
   PubMed Web of Science ®Google Scholar
• van Rossum T. G., Vulto A. G., de Man R. A., Brouwer J. T., Schalm S. W. Review Article: Glycyrrhizin as a Potential Treatment for Chronic Hepatitis C. Aliment. Pharmacol. Ther. 1998; 12(3)199–205
   PubMed Web of Science ®Google Scholar
• Revers F. E. Heeft Succus Liquiritae een Genezende Werking op de Maagzweer?. Nederlands Tijdschr. Geneeskunde 1946; 90: 135–137
   PubMedGoogle Scholar
• Størmer F. C., Reistad R., Alexander J. Glycyrrhizic Acid in Liquorice—Evaluation of Health Hazard. Food Addit. Contam. 1993; 31(4)303–312
   Google Scholar
• Hulshof K. F.A.M., Kistemaker C. The Consumption of Licorice and the Intake of Ammonium Chloride Among Dutch Population Groups (Second Dutch National Food Consumption Survey). TNO Nutrition and Food Research Institute, Zeist 1994; 94: 298
   Google Scholar
• Maas P. Zoethout in Levensmiddelen: Onderzoek naar het Glycyrrhizine-Gehalte van Thee, Kruidenmengsels, Dranken en Drop. De ware(n)-Chemicus 2000; 30: 65–74
   Google Scholar
• Spinks E. A., Fenwick G. R. The Determination of Glycyrrhizin in Selected UK Liquorice Products. Food Addit. Contam. 1990; 7(6)769–778
   PubMed Web of Science ®Google Scholar
• Yamamura Y., Santa T., Kotaki H., Uchino K., Sawada Y., Iga T. Administration-Route Dependency of Absorption of Glycyrrhizin in Rats: Intraperitoneal Administration Dramatically Enhanced Bioavailability. Biol. Pharm. Bull. 1995; 18(2)337–341
   PubMed Web of Science ®Google Scholar
• Sakiya Y., Akado Y., Kawano S., Miyauchi Y. Rapid Estimation of Glycyrrhizin and Glycyrrhetinic Acid in Plasma by High-Speed Liquid Chromatography. Chem. Pharm. Bull. 1979; 27: 1125–1129
   PubMed Web of Science ®Google Scholar
• Cantelli-Forti G., Maffei F., Hrelia P., Bugamelli F., Bernardi M., D'Intino P., Maranesi M., Raggi M. A. Interaction of Licorice on Glycyrrhizin Pharmacokinetics. Environ. Health Perspect. 1994; 9(65)65–68
   Google Scholar
• Wang Z., Kurosaki Y., Nakayama T., Kimura T. Mechanism of Gastrointestinal Absorption of Glycyrrhizin in Rats. Biol. Pharm. Bull. 1994; 17(10)1399–1403
   PubMed Web of Science ®Google Scholar
• Yamamura Y., Kawakami J., Santa T., Kotaki H., Uchino K., Sawada Y., Tanaka N., Iga T. Pharmacokinetic Profile of Glycyrrhizin in Healthy Volunteers by a New High-Performance Liquid Chromatographic Method. J. Pharm. Sci. 1992; 81(10)1042–1046
   PubMed Web of Science ®Google Scholar
• Groot de G., Koops R., Hogendoorn E. A., Goewie C. E., Savelkoul T. J., van Vlsten P. Improvement of Selectivity and Sensitivity by Column Switching in the Determination of Glycyrrhizin and Glycyrrhetic Acid in Human Plasma by High-Performance Liquid Chromatography. J. Chromatogr. 1988; 456(1)71–81
   PubMed Web of Science ®Google Scholar
• Gunnarsdottir S., Johannesson T. Glycyrrhetic Acid in Human Blood After Ingestion of Glycyrrhizic Acid in Licorice. Pharmacol. Toxicol. 1997; 81(6)300–302
   PubMedGoogle Scholar
• Wang Z., Nishioka M., Kurosaki Y., Nakayama T., Kimura T. Gastrointestinal Absorption Characteristics of Glycyrrhizin from Glycyrrhiza Extract. Biol. Pharm. Bull. 1995; 18(9)1238–1241
   PubMed Web of Science ®Google Scholar
• Takeda S., Ishihara K., Wakui Y., Amagaya S., Maruno M., Akao T., Kobashi K. Bioavailability Study of Glycyrrhetic Acid After Oral Administration of Glycyrrhizin in Rats; Relevance to the Intestinal Bacterial Hydrolysis. J. Pharm. Pharmacol. 1996; 48(9)902–905
   PubMed Web of Science ®Google Scholar
• Takeda S., Ono H., Wakui Y., Asami A., Matsuzaki Y., Sasaki H., Aburada M., Hosoya E. Determination of Glycyrrhetic Acid in Human Serum by High-Performance Liquid Chromatography with Ultraviolet Detection. J. Chromatogr. B: Biomed. Appl. 1990; 530(2)447–451
   Google Scholar
• Akao T., Akao T., Kobashi K. Glycyrrhizin Beta-D-Glucuronidase of Eubacterium sp. from Human Intestinal Flora. Chem. Pharm. Bull. 1987; 35(2)705–710
   PubMed Web of Science ®Google Scholar
• Akao T., Hayashi T., Kobashi K., Kanaoka M., Kato H., Kobayashi M., Takeda S., Oyama T. Intestinal Bacterial Hydrolysis Is Indispensable to Absorption of 18 Beta-glycyrrhetic Acid after Oral Administration of Glycyrrhizin in Rats. J. Pharm. Pharmacol. 1994; 46(2)135–137
   PubMed Web of Science ®Google Scholar
• Akao T. Localization of Enzymes Involved in Metabolism of Glycyrrhizin in Contents of Rat Gastrointestinal Tract. Biol. Pharm. Bull. 1997; 20(2)122–126
   PubMed Web of Science ®Google Scholar
• Hattori M., Sakamoto T., Kobashi K., Namba T. Metabolism of Glycyrrhizin by Human Intestinal Flora. Planta Med. 1983; 1(48)38–42
   Google Scholar
• Hattori M., Sakamoto T., Yamagishi T., Sakamoto K., Konishi K., Kobashi K., Namba T. Metabolism of Glycyrrhizin by Human Intestinal Flora. II. Isolation and Characterization of Human Intestinal Bacteria Capable of Metabolizing Glycyrrhizin and Related Compounds. Chem. Pharm. Bull. 1985; 33(1)210–217
   PubMed Web of Science ®Google Scholar
• Imai T., Sakai M., Ohtake H., Azuma H., Otagiri M. Vitro and In Vivo Evaluation of the Enhancing Activity of Glycyrrhizin on the Intestinal Absorption of Drugs. Pharm. Res. 1999; 16(1)80–86
   PubMed Web of Science ®Google Scholar
• Krahenbuhl S., Hasler F., Frey B. M., Frey F. J., Brenneisen R., Krapf R. Kinetics and Dynamics of Orally Administered 18 Beta-glycyrrhetinic Acid in Humans. J. Clin. Endocrinol. Metab. 1994; 78(3)581–585
   PubMed Web of Science ®Google Scholar
• Parke D. V., Pollock S., Williams R. T. The Fate of Tritium-Labelled β-Glycyrrhetic Acid in the Rat. J. Pharm. Pharmacol. 1963; 15: 500–506
   PubMed Web of Science ®Google Scholar
• Buhler H., Perschel F. H., Fitzner R., Hierholzer K. Endogenous inhibitors of 11 Beta-OHSD: Existence and Possible Significance. Steroids 1994; 59(2)131–135
   PubMed Web of Science ®Google Scholar
• Ishida S., Sakiya Y., Ichikawa T., Awazu S. Pharmacokinetics of Glycyrrhetic Acid, a Major Metabolite of Glycyrrhizin, in Rats. Chem. Pharm. Bull. 1989; 37(9)2509–2513
   PubMed Web of Science ®Google Scholar
• Ishida S., Sakiya Y., Ichikawa T., Kinoshita M., Awazu S. Binding of Glycyrrhizin to Human Serum and Human Serum Albumin. Chem. Pharm. Bull. 1989; 37(1)226–228
   PubMed Web of Science ®Google Scholar
• Rowland M., Tozer T. N. Clinical Pharmacokinetics. 2nd Ed., Lea & Febiger, Philadelphia 1989
   Google Scholar
• Ishida S., Ichikawa T., Sakiya Y. Binding of Glycyrrhetinic Acid to Rat Plasma, Rat Serum Albumin, Human Serum, and Human Serum Albumin. Chem. Pharm. Bull. 1988; 36(1)440–443
   PubMed Web of Science ®Google Scholar
• Ishida S., Sakiya Y., Ichikawa T., Taira Z., Awazu S. Prediction of Glycyrrhizin Disposition in Rat and Man by a Physiologically Based Pharmacokinetic Model. Chem. Pharm. Bull. 1990; 38(1)212–218
   PubMed Web of Science ®Google Scholar
• Ishida S., Sakiya Y., Ichikawa T., Taira Z. Dose-Dependent Pharmacokinetics of Glycyrrhizin in Rats. Chem. Pharm. Bull. 1992; 40(7)1917–1920
   PubMed Web of Science ®Google Scholar
• Tsai T. H., Liao J. F., Shum A. Y., Chen C. F. Pharmacokinetics of Glycyrrhizin After Intravenous Administration to Rats. J. Pharm. Sci. 1992; 81(9)961–963
   PubMed Web of Science ®Google Scholar
• Ichikawa T., Ishida S., Sakiya Y., Sawada Y., Hanano M. Biliary Excretion and Enterohepatic Cycling of Glycyrrhizin in Rats. J. Pharm. Sci. 1986; 75: 672–675
   PubMed Web of Science ®Google Scholar
• Shimamura H., Suzuki H., Tagaya O., Horie T., Sugiyama Y. Biliary Excretion of Glycyrrhizin in Rats: Kinetic Basis for Multiplicity in Bile Canalicular Transport of Organic Anions. Pharm. Res. 1996; 13(12)1833–1837
   PubMed Web of Science ®Google Scholar
• Ichikawa T., Ishida S., Sakiya Y., Akada Y. High-Performance Liquid Chromatographic Determination of Glycyrrhizin and Glycyrrhetinic Acid in Biological Materials. Chem. Pharm. Bull. 1984; 32(9)3734–3738
   PubMed Web of Science ®Google Scholar
• Kawakami J., Yamamura Y., Santa T., Kotaki H., Uchino K., Sawada Y., Iga T. Kinetic Analysis of Glycyrrhetic Acid, an Active Metabolite of Glycyrrhizin, in Rats: Role of Enterohepatic Circulation. J. Pharm. Sci. 1993; 82(3)301–305
   PubMed Web of Science ®Google Scholar
• Tsai T. H., Chen C. F. High-Performance Liquid Chromatography Determination of 18 Alfa-glycyrrhetinic Acid and 18 Beta-glycyrrhetinic Acid in Rat Plasma: Application to Pharmacokinetic Study. J. Chromatogr. B: Biomed. Appl. 1991; 567: 405–414
   Google Scholar
• Laub P. B., Gallo J. M. NCOMP—A Windows-Based Computer Program for Noncompartmental Analysis of Pharmacokinetic Data. J. Pharm. Sci. 1996; 85(4)393–395
   PubMed Web of Science ®Google Scholar
• Purves R. D. Optimum Numerical Integration Methods for Estimation of Area-Under-the-Curve (AUC) and Area-Under-the-Moment-Curve (AUMC). J. Pharmacokinet. Biopharm. 1992; 20(3)211–226
   PubMedGoogle Scholar
• Lin J. H. Dose-Dependent Pharmacokinetics: Experimental Observations and Theoretical Considerations. Biopharm. Drug Dispos. 1994; 15: 1–31
   PubMed Web of Science ®Google Scholar
• Akao T., Akao T., Hattori M., Kanaoka M., Yamamoto K., Namba T., Kobashi K. Hydrolysis of Glycyrrhizin to 18 Beta-glycyrrhetyl Monoglucuronide by Lysosomal Beta-D-Glucuronidase of Animal Livers. Biochem. Pharmacol. 1991; 41(6–7)1025–1029
   PubMed Web of Science ®Google Scholar
• Ishida S., Sakiya Y., Ichikawa T., Taira Z. Uptake of Glycyrrhizin by Isolated Rat Hepatocytes. Biol. Pharm. Bull. 1993; 16(3)293–297
   PubMed Web of Science ®Google Scholar
• Ishida S., Sakiya Y., Taira Z. Disposition of Glycyrrhizin in the Perfused Liver of Rats. Biol. Pharm. Bull. 1994; 17(7)960–969
   PubMed Web of Science ®Google Scholar
• Yamamura Y., Kawakami J., Santa T., Kotaki H., Uchino K., Sawada Y., Iga T. Selective High-Performance Liquid Chromatographic Method for the Determination of Glycyrrhizin and Glycyrrhetic Acid-3-O-glucuronide in Biological Fluids: Application of Ion-Pair Extraction and Fluorescence Labelling Agent. J. Chromatogr. B: Biomed. Appl. 1991; 567(1)151–160
   Google Scholar
• Wang Z., Okamoto M., Kurosaki Y., Nakayama T., Kimura T. Pharmacokinetics of Glycyrrhizin in Rats with D-Galactosamine-Induced Hepatic Disease. Biol. Pharm. Bull. 1996; 19(6)901–904
   PubMed Web of Science ®Google Scholar
• Hasler F., Krapf R., Brenneisen R., Bourquin D., Krahenbuhl S. Determination of 18 Beta-glycyrrhetinic Acid in Biological Fluids from Humans and Rats by Solid-Phase Extraction and High-Performance Liquid Chromatography. J. Chromatogr. B: Biomed. Appl. 1993; 620(1)73–82
   Web of Science ®Google Scholar
• Elferink R. P.J.Oude, Meijer D. K.F., Kuipers F., Jansen P. L.M., Groen A. K., Groothuis G. M.M. Hepatobiliary Secretion of Organic Compounds; Molecular Mechanisms of Membrane Transport. Biochim. Biophys. Acta 1995; 1241: 215–268
   PubMed Web of Science ®Google Scholar
• van Rossum T. G., Vulto A. G., Hop W. C., Brouwer J. T., Niesters H. G., Schalm S. W. Intravenous Glycyrrhizin for the Treatment of Chronic Hepatitis C: A Double-Blind, Randomized, Placebo-Controlled Phase I/II Trial. J. Gastroenterol. Hepatol. 1999; 14(11)1093–1099
   PubMed Web of Science ®Google Scholar
• Yamamura Y., Tanaka N., Santa T., Kotaki H., Aikawa T., Uchino K., Osuga T., Sawada Y., Iga T. The Relationship Between Pharmacokinetic Behaviour of Glycyrrhizin and Hepatic Function in Patients with Acute Hepatitis and Liver Cirrhosis. Biopharm. Drug Dispos. 1995; 16(1)13–21
   PubMed Web of Science ®Google Scholar
• Tanaka N., Yamamura Y., Santa T., Kotaki H., Uchino K., Sawada Y., Aikawa T., Osuga T., Iga T. Pharmacokinetic profiles of glycyrrhizin in patients with chronic hepatitis. Biopharm. Drug Dispos. 1993; 14(7)609–614
   PubMed Web of Science ®Google Scholar
• Iveson P., Lindup W. E., Parke D. V., Williams R. T. The Metabolism of Carbenoxolone in the Rat. Xenobiotica 1971; 1(1)79–95
   PubMedGoogle Scholar
• Kanaoka M., Yano S., Kato H., Nakada T. Synthesis and Separation of 18Betaglycerrhetyl Monoglucuronide from Serum of a Patient with Glycyrrhizin Induced Pseudo-aldosteronism. Chem. Pharm. Bull. 1986; 34(12)4978–4983
   PubMed Web of Science ®Google Scholar
• Sinclair K. A., Caldwell J. The Formation of Beta-glucuronidase Resistant Glucuronides by the Intramolecular Rearrangement of Glucuronic Acid Conjugates at Mild Alkaline pH. Biochem. Pharmacol. 1982; 6(31)953–957
   Google Scholar
• Faed E. M. Properties of Acyl Glucuronides: Implications for Studies of the Pharmacokinetics and Metabolism of Acidic Drugs. Drug Metab. Rev. 1984; 5(6)1213–1249
   Google Scholar
• Spahn-Langguth H., Benet L. Z. Acyl Glucuronides Revisited: Is the Glucuronidation Process a Toxification as Well as a Detoxification Mechanism?. Drug Metab. Rev. 1992; 1(24)5–47
   Google Scholar
• Akao T. Hydrolysis of Glycyrrhetyl Mono-glucuronide to Glycyrrhetic Acid by Glycyrrhetyl Mono-glucuronide Beta-D-glucuronidase of Eubacterium sp GLH. Biol. Pharm. Bull. 1997b; 20(12)1245–1249
   PubMed Web of Science ®Google Scholar
• Andersen M. E., Clewell H. J., 3rd, Frederick C. B. Applying Simulation Modeling to Problems in Toxicology and Risk Assessment—A Short Perspective. Toxicol. Appl. Pharmacol. 1995; 133(2)181–187
   PubMed Web of Science ®Google Scholar
• DeJongh J., Blaauboer B. J. Simulation of Toluene Kinetics in the Rat by a Physiologically Based Pharmacokinetic Model with Application of Biotransformation Parameters Derived Independently In Vitro and In Vivo. Fundam. Appl. Toxicol. 1996; 32(2)260–268
   PubMedGoogle Scholar
• Ploeger B. A., Meulenbelt J., DeJongh J. Physiologically Based Pharmacokinetic Modeling of Glycyrrhizic Acid, a Compound Subject to Presystemic Metabolism and Enterohepatic Cycling. Toxicol. Appl. Pharmacol. 2000; 162(3)177–188
   PubMed Web of Science ®Google Scholar
• Buhler H., Perschel F. H., Hierholzer K. Inhibition of Rat Renal 11 Beta-hydroxysteroid Dehydrogenase by Steroidal Compounds and Triterpenoids; Structure/Function Relationship Biochim. Biophys. Acta 1991; 1075(3)206–212
   PubMed Web of Science ®Google Scholar
• Ploeger B. A., Mensinga T., Sips A. J.A.M., Meulenbelt J., DeJongh J. A Human Physiologically Based Model for Glycyrrhizic Acid, a Compound Subject to Presystemic Metabolism and Enterohepatic Cycling. Pharm. Res. 2000; 17(12)1516–1525
   PubMed Web of Science ®Google Scholar
• Niinuma K., Kato Y., Suzuki H., Tyson C. A., Weizer V., Dabbs J. E., Froehlich R., Green C. E., Sugiyama Y. Primary Active Transport of Organic Anions on Bile Canalicular Membrane in Humans. Am. J. Physiol. 1999; 276(5 Pt 1)G1153–G1164
   PubMed Web of Science ®Google Scholar
• Abe K., Suzuki A., Katayama H., Tatsumi Y., Yumioka E. Determination of 18 Beta-glycyrrhetic Acid in Human Plasma by High-Performance Liquid Chromatography. J. Chromatogr. B: Biomed. Appl. 1994; 653(1)112–115
   PubMedGoogle Scholar
• Krahenbuhl S., Hasler F., Krapf R. Analysis and Pharmacokinetics of Glycyrrhizic Acid and Glycyrrhetinic Acid in Humans and Experimental Animals. Steroids 1994; 59(2)121–126
   PubMed Web of Science ®Google Scholar
• Ploeger B. A., Mensinga T., Sips A. J.A.M., Deerenberg C., Meulenbelt J., De-Jongh J. A. Population PBPK/PD Model for the Inhibition of 11-Beta-hydroxysteroid Dehydrogenase by Glycyrrhizic Acid. Toxicol. Appl. Pharmacol. 2001; 170(1)46–55
   PubMed Web of Science ®Google Scholar
• Nakamura K., Motohashi Y., Kikuchi S., Tanaka M., Nakano S. Liver Transferase Activity in Healthy Japanese Employees Aged 18–39 Years. Ind. Health 1998; 36(3)218–222
   PubMed Web of Science ®Google Scholar
• Arndt V., Brenner H., Rothenbacher D., Zschenderlein B., Fraisse E., Fliedner T. M. Elevated Liver Enzyme Activity in Construction Workers: Prevalence and Impact on Early Retirement and All-Cause Mortality. Int. Arch. Occup. Environ. Health 1998; 71(6)405–412
   PubMed Web of Science ®Google Scholar
• Morgan D. J., McLean A. J. Clinical Pharmacokinetic and Pharmacodynamic Considerations in Patients with Liver Disease. An Update. Clin. Pharmacokinet. 1995; 29(5)370–391
   PubMed Web of Science ®Google Scholar
• Clewell H. J., 3rd, Jarnot B. M. Incorporation of Pharmacokinetics in Noncancer Risk Assessment: Example with Chloropentafluorobenzene. Risk Anal. 1994; 14(3)265–276
   PubMed Web of Science ®Google Scholar
• O'Donnell L. J., Virjee J., Heaton K. W. Detection of Pseudodiarrhoea by Simple Clinical Assessment of Intestinal Transit Rate. Br. Med. J. 1990; 300(6722)439–440
   PubMed Web of Science ®Google Scholar
• Heaton K. W., O'Donnell L. An Office Guide to Whole-Gut Transit Time. Patients' Recollection of Their Stool Form. J. Clin. Gastroenterol. 1994; 19(1)28–30
   PubMed Web of Science ®Google Scholar
• Madsen J. L. Effects of Gender, Age, and Body Mass Index on Gastrointestinal Transit Times. Dig. Dis. Sci. 1992; 37(10)1548–1553
   PubMed Web of Science ®Google Scholar
• Meier R., Beglinger C., Dederding J. P., Wyss B. Meyer, Fumagalli M., Rowedder A., Turberg Y., Brignoli R. Influence of Age, Gender, Hormonal Status and Smoking Habits on Colonic Transit Time. Neurogastroenterol. Motil. 1995; 7(4)235–238
   PubMed Web of Science ®Google Scholar
• Degen L. P., Phillips S. F. Variability of Gastrointestinal Transit in Healthy Women and Men. Gut 1996; 39(2)299–305
   PubMed Web of Science ®Google Scholar
• McLean R. G., Smart R. C., Lubowski D. Z., King D. W., Barbagallo S., Talley N. A. Oral Colon Transit Scintigraphy Using Indium-111 DTPA: Variability in Healthy Subjects. Int. J. Colorectal Dis. 1992; 7(4)173–176
   PubMed Web of Science ®Google Scholar